Analysis of the CTRP and GDSC databases revealed that the VPS35 expression level was correlated with sensitivity to multiple chemotherapeutic agents (e.g., doxorubicin, BRD1812, PLX4720) across pan-cancer (Fig. 11B and C). Here, VPS35 is linked to cancer.